Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 07:18 am Sale | 2025-06-30 | 13G | Blueprint Medicines Corporation BPMC | Avoro Capital Advisors LLC | 375,000 0.600% | -3,475,000 (-90.26%) | Filing History |
| 2025-08-14 07:13 am Sale | 2025-06-30 | 13G | Soleno Therapeutics, Inc. SLNO | Avoro Capital Advisors LLC | 2,050,000 4.100% | -131,000 (-6.01%) | Filing History |
| 2025-08-14 07:10 am Sale | 2025-06-30 | 13G | Monte Rosa Therapeutics, Inc. GLUE | Avoro Capital Advisors LLC | 3,725,000 6.100% | -620,000 (-14.27%) | Filing History |
| 2025-08-14 07:07 am Sale | 2025-06-30 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR | Avoro Capital Advisors LLC | 11,517,441 8.300% | -511,111 (-4.25%) | Filing History |
| 2025-08-14 07:04 am Purchase | 2025-06-30 | 13G | Tourmaline Bio, Inc. TRML | Avoro Capital Advisors LLC | 2,555,555 9.950% | 333,333 (+15.00%) | Filing History |
| 2025-08-14 06:59 am Purchase | 2025-06-30 | 13G | uniQure N.V. QURE | Avoro Capital Advisors LLC | 3,625,000 6.600% | 3,625,000 (New Position) | Filing History |
| 2025-08-14 06:57 am Purchase | 2025-06-30 | 13G | MoonLake Immunotherapeutics MLTX | Avoro Capital Advisors LLC | 4,150,000 6.500% | 4,150,000 (New Position) | Filing History |
| 2025-05-15 09:31 am Sale | 2025-03-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | Avoro Capital Advisors LLC | 8,700,000 4.200% | -4,350,000 (-33.33%) | Filing History |
| 2025-05-15 09:30 am Sale | 2025-03-31 | 13G | Amicus Therapeutics, Inc. FOLD | Avoro Capital Advisors LLC | 20,500,000 6.700% | -2,675,000 (-11.54%) | Filing History |
| 2025-05-15 09:30 am Purchase | 2025-03-31 | 13G | Blueprint Medicines Corporation BPMC | Avoro Capital Advisors LLC | 3,850,000 6.000% | 3,850,000 (New Position) | Filing History |
| 2025-03-04 5:58 pm Purchase | 2025-02-28 | 13D | Whitehawk Therapeutics Inc WHWK | Avoro Capital Advisors LLC | 11,914,961 19.990% | 8,333,000 (+232.64%) | Filing History |
| 2025-02-14 09:31 am Purchase | 2024-12-31 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR | Avoro Capital Advisors LLC | 12,028,552 9.600% | 3,139,664 (+35.32%) | Filing History |
| 2025-02-14 09:30 am Purchase | 2024-12-31 | 13G | Vera Therapeutics, Inc. VERA | Avoro Capital Advisors LLC | 5,610,000 8.900% | 1,300,410 (+30.17%) | Filing History |
| 2025-02-14 09:30 am Sale | 2024-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE | Avoro Capital Advisors LLC | 4,345,000 7.100% | -190,000 (-4.19%) | Filing History |
| 2024-12-23 3:51 pm Purchase | 2024-12-19 | 13D | Whitehawk Therapeutics Inc WHWK | Avoro Capital Advisors LLC | 3,581,961 14.500% | 110,209 (+3.17%) | Filing History |
| 2024-11-14 09:40 am Purchase | 2024-09-30 | 13G | Taysha Gene Therapies, Inc. TSHA | Avoro Capital Advisors LLC | 23,094,444 9.990% | 23,094,444 (New Position) | Filing History |
| 2024-11-14 09:39 am Purchase | 2024-09-30 | 13G | Tourmaline Bio, Inc. TRML | Avoro Capital Advisors LLC | 2,222,222 8.700% | 2,222,222 (New Position) | Filing History |
| 2024-11-14 09:39 am Purchase | 2024-09-30 | 13G | Avidity Biosciences, Inc. RNA | Avoro Capital Advisors LLC | 9,935,792 8.300% | 9,935,792 (New Position) | Filing History |
| 2024-11-14 09:38 am Purchase | 2024-09-30 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR | Avoro Capital Advisors LLC | 8,888,888 7.200% | 8,888,888 (New Position) | Filing History |
| 2024-11-14 09:37 am Purchase | 2024-09-30 | 13G | Ocular Therapeutix, Inc. OCUL | Avoro Capital Advisors LLC | 12,714,874 7.900% | 12,714,874 (New Position) | Filing History |